Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
Msystems|November 13, 2018
Multiple Sclerosis-Associated Changes in the Composition and Immune Functions of Spore-Forming BacteriaEgle Cekanaviciute, Anne-Katrin Pröbstel, Anna Thomann, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Persistent Classical and Atypical Memory B Cells Underlie Heterogeneous Vaccine Responses in Ocrelizumab-Treated Multiple SclerosisRyan Curtin, Yogambigai Velmurugu, Fatoumatta Dibba, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 18, 2023
T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunitySharon A Sagan, Zahra Moinfar, Carson E Moseley, et al.
Frontiers in Neurology|March 6, 2023
SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumabJeffrey L Bennett, Kazuo Fujihara, Ho Jin Kim, et al.
Nature Immunology|May 5, 2015
The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosisMichio Onizawa, Shigeru Oshima, Ulf Schulze-Topphoff, et al.
Archives of Neurology|August 12, 2009
Depletion of B lymphocytes from cerebral perivascular spaces by rituximabMaria del Pilar Martin, Petra D Cravens, Ryan Winger, et al.
Multiple Sclerosis and Related Disorders|January 6, 2023
Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulatorsJoseph J Sabatino, Kristen Mittl, William Rowles, et al.
The Journal of Experimental Medicine|December 11, 2013
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodiesNicolas Molnarfi, Ulf Schulze-Topphoff, Martin S Weber, et al.
Archives of Neurology|July 14, 2010
Translational research in neurology and neuroscience 2010: multiple sclerosisOlaf Stüve, Bernd C Kieseier, Bernhard Hemmer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 15, 2023
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine dosesFrederik Novak, Hamza Mahmood Bajwa, John Eugenio Coia, et al.
Pageof 18